Effects of Sitagliptin in Relatives of T1D Patients

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Type 1 Diabetes
Interventions
DRUG

Sitagliptin

The dose of sitagliptin will be established on the basis of the estimated glomerular filtrate: 100 mg in single daily administration (estimated glomerular filtration rate less than or equal to 45 mL / min / 1.73 m2) or 50 mg (estimated glomerular filtration rate 30-45 mL / min / 1.73 m2)

DEVICE

Professional CGM

The sensor records the patient's glucose readings every 15 minutes for up to 14 days.

Trial Locations (1)

20157

ASST FBF Sacco, Milan

All Listed Sponsors
lead

University of Milan

OTHER

NCT05219409 - Effects of Sitagliptin in Relatives of T1D Patients | Biotech Hunter | Biotech Hunter